Close Menu

NEW YORK ─ The US Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA) has awarded Luminex almost $5.4 million for product development on its expanded NxTag Respiratory Pathogen Panel (RPP), the diagnostic firm said on Thursday.

Austin, Texas-based Luminex said the BARDA award is also intended to support a 510(k) filing for clearance of the panel with the US Food and Drug Administration.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.